FDA ORDERS CLASS 1 RECALL OF FRESENIUS' NATURALYTE LIQUID AND GRANUFLO DRY ACID CONCENTRATE DUE TO EXTREME HEART ATTACK RISK!
HAVE YOU OR A LOVED ONE SUFFERED A HEART ATTACK IN DIALYSIS?
YOU MAY HAVE A CLAIM FOR SUBSTANTIAL DAMAGES
WE CAN HELP - call 1-800-331-2782 for a free consultation
The national law firm Kreindler & Kreindler LLP, with offices in New York, Los Angeles and Boston, is offering free consultations for patients or families injured after being administered Fresenius' Naturalyte liquid and GranuFlo dry acid concentrate during dialysis. The government has found that these drugs are unsafe and can cause:
- Cardiopulmonary arrest
- Low blood pressure
- Cardiac arrhythmia
Investigation has disclosed that Fresenius Medical Care North America, based in Waltham Massachusetts, knew its product posed a serious risk of injury and death for certain identifiable dialysis patients. Fresenius Medical Care failed to disclose this critical information to the government or health care providers, which allowed continued high dose administration of the drug in high risk patients and led to avoidable injury and death.
Fresenius Medical Care is the largest operator of hemodialysis clinics in the United States. It is also a leading supplier of dialysis machines and dialysis supplies. There is evidence that information about dosage risk was given to Fresenius operated clinics but was withheld from other clinics using its GranuFlo and Naturalyte products. The company is currently being investigated for failing to inform consumers of the risks connected to excessive doses of its dialysis products.
For more information, call 1-800 331-2782 or fill out the form below and an attorney from Kreindler & Kreindler LLP will contact you to discuss your claim.